CD19-positive ALL
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Anti-CD19/CD22 Bispecific CAR-T Cell Therapy for CD19-positive ALL (NCT04303520) | The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine | 2018-05-03 |
Track CD19-positive ALL automatically
Every clearance here is in the API, with alerts when new ones post.